Muzz a are you serious a you see this as good
A pharma company that cuts its R and D to preserve cash but continues to pay its management the same highly lucrative salaries .
A company that relocated for the convenience of the MD , who as of today has been in charge of severe underperformance resulting in loss of Barda contract
In all seriousness - what has RB offered since taking over . Has a marketed the company successfully - nope silent for about a year
Did he help drive SP value - nope .
Did he raise capital at SP highs - nope
Has he bought a single share since he took over - nope
Has his management acquired stock - nope - even at these levels
Biota has been moved to the US for the convenience of the Chairman and then relocated inside the USA for the convenience of the CEO . In case Australian shareholders request a move back to AUS, lets make sure we shut down Australian operations completely so there is no reason to move back , we wouldn't want the MD travelling more than 10 min to get to the office
The save 8 m a year but get rid of the actual brains. - how much to we pay management a year - dont look unless you want to cry . But a guess cash has to be preserved to pay themselves handsomely before their next role of the dice
- Forums
- ASX - By Stock
- BTA
- restructuring plan
restructuring plan, page-7
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online